CBT vs. CPRX
Compare and contrast key facts about Cabot Corporation (CBT) and Catalyst Pharmaceuticals, Inc. (CPRX).
Performance
CBT vs. CPRX - Performance Comparison
Loading graphics...
CBT vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CBT Cabot Corporation | 14.30% | -25.68% | 11.25% | 27.63% | 21.38% | 28.40% | -2.16% | 14.25% | -28.70% | 24.65% |
CPRX Catalyst Pharmaceuticals, Inc. | 6.08% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Fundamentals
CBT:
$8.70
CPRX:
$1.68
CBT:
8.65
CPRX:
14.71
CBT:
0.46
CPRX:
0.26
CBT:
0.75
CPRX:
5.35
CBT:
$3.61B
CPRX:
$588.99M
CBT:
$705.00M
CPRX:
$726.82M
CBT:
$596.00M
CPRX:
$257.78M
Returns By Period
In the year-to-date period, CBT achieves a 14.30% return, which is significantly higher than CPRX's 6.08% return. Over the past 10 years, CBT has underperformed CPRX with an annualized return of 7.01%, while CPRX has yielded a comparatively higher 35.35% annualized return.
CBT
- 1D
- -0.26%
- 1M
- -1.09%
- YTD
- 14.30%
- 6M
- 0.33%
- 1Y
- -7.17%
- 3Y*
- 1.54%
- 5Y*
- 9.48%
- 10Y*
- 7.01%
CPRX
- 1D
- 4.12%
- 1M
- 7.28%
- YTD
- 6.08%
- 6M
- 25.69%
- 1Y
- 2.10%
- 3Y*
- 14.30%
- 5Y*
- 40.58%
- 10Y*
- 35.35%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CBT vs. CPRX — Risk / Return Rank
CBT
CPRX
CBT vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cabot Corporation (CBT) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CBT | CPRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.22 | 0.06 | -0.28 |
Sortino ratioReturn per unit of downside risk | -0.10 | 0.32 | -0.42 |
Omega ratioGain probability vs. loss probability | 0.99 | 1.04 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | -0.21 | 0.01 | -0.22 |
Martin ratioReturn relative to average drawdown | -0.46 | 0.02 | -0.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CBT | CPRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.22 | 0.06 | -0.28 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | 0.85 | -0.56 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | 0.56 | -0.37 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.08 | +0.14 |
Correlation
The correlation between CBT and CPRX is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CBT vs. CPRX - Dividend Comparison
CBT's dividend yield for the trailing twelve months is around 2.39%, while CPRX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CBT Cabot Corporation | 2.39% | 2.69% | 1.85% | 1.88% | 2.21% | 2.53% | 3.12% | 2.90% | 3.04% | 2.02% | 2.22% | 2.15% |
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
CBT vs. CPRX - Drawdown Comparison
The maximum CBT drawdown since its inception was -82.87%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for CBT and CPRX.
Loading graphics...
Drawdown Indicators
| CBT | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.87% | -94.25% | +11.38% |
Max Drawdown (1Y)Largest decline over 1 year | -29.59% | -27.29% | -2.30% |
Max Drawdown (5Y)Largest decline over 5 years | -48.78% | -45.37% | -3.41% |
Max Drawdown (10Y)Largest decline over 10 years | -67.20% | -64.87% | -2.33% |
Current DrawdownCurrent decline from peak | -33.44% | -5.89% | -27.55% |
Average DrawdownAverage peak-to-trough decline | -20.79% | -52.51% | +31.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.52% | 15.10% | -1.58% |
Volatility
CBT vs. CPRX - Volatility Comparison
The current volatility for Cabot Corporation (CBT) is 9.06%, while Catalyst Pharmaceuticals, Inc. (CPRX) has a volatility of 10.39%. This indicates that CBT experiences smaller price fluctuations and is considered to be less risky than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CBT | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.06% | 10.39% | -1.33% |
Volatility (6M)Calculated over the trailing 6-month period | 22.69% | 23.71% | -1.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.90% | 34.96% | -2.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.41% | 48.24% | -14.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.26% | 62.81% | -27.55% |
Financials
CBT vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Cabot Corporation and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities